Qiongyu Hao

1.1k total citations
28 papers, 789 citations indexed

About

Qiongyu Hao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Qiongyu Hao has authored 28 papers receiving a total of 789 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Qiongyu Hao's work include MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Qiongyu Hao is often cited by papers focused on MicroRNA in disease regulation (6 papers), RNA modifications and cancer (6 papers) and Circular RNAs in diseases (5 papers). Qiongyu Hao collaborates with scholars based in United States, China and France. Qiongyu Hao's co-authors include Jaydutt V. Vadgama, Piwen Wang, Yong Wu, Wei Cao, Jieqing Li, Yanyuan Wu, Yong-Xiao Wang, Wenhong Deng, Long Zhang and Yun‐Min Zheng and has published in prestigious journals such as Oncogene, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Qiongyu Hao

25 papers receiving 783 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiongyu Hao United States 15 424 220 218 153 81 28 789
Liwen Li China 22 669 1.6× 220 1.0× 255 1.2× 216 1.4× 86 1.1× 58 1.2k
Claudia Geismann Germany 17 636 1.5× 182 0.8× 246 1.1× 148 1.0× 60 0.7× 26 953
Shiguo Zhu China 19 556 1.3× 191 0.9× 220 1.0× 167 1.1× 85 1.0× 35 886
Jian Pang China 15 341 0.8× 194 0.9× 182 0.8× 132 0.9× 104 1.3× 34 700
Xiaocong Pang China 16 506 1.2× 230 1.0× 168 0.8× 116 0.8× 153 1.9× 45 873
Yu‐Chang Liu Taiwan 20 421 1.0× 160 0.7× 177 0.8× 88 0.6× 87 1.1× 34 748
Mudan Lu China 17 564 1.3× 199 0.9× 136 0.6× 108 0.7× 118 1.5× 36 856
Remya Raja India 15 361 0.9× 175 0.8× 161 0.7× 120 0.8× 64 0.8× 29 807
Sailan Zou China 9 561 1.3× 259 1.2× 348 1.6× 226 1.5× 105 1.3× 11 1.0k
Katarzyna Kulcenty Poland 17 377 0.9× 156 0.7× 192 0.9× 92 0.6× 67 0.8× 48 766

Countries citing papers authored by Qiongyu Hao

Since Specialization
Citations

This map shows the geographic impact of Qiongyu Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiongyu Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiongyu Hao more than expected).

Fields of papers citing papers by Qiongyu Hao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiongyu Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiongyu Hao. The network helps show where Qiongyu Hao may publish in the future.

Co-authorship network of co-authors of Qiongyu Hao

This figure shows the co-authorship network connecting the top 25 collaborators of Qiongyu Hao. A scholar is included among the top collaborators of Qiongyu Hao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiongyu Hao. Qiongyu Hao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Ning, Peipei Zhang, Yi-Xin Chang, et al.. (2025). XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1. Cell Death and Disease. 16(1). 205–205. 2 indexed citations
2.
Zhang, Peijie, Xueyan Chen, Qiongyu Hao, et al.. (2025). Grid hollow octet truss lattices that are stable at low relative density. Journal of the Mechanics and Physics of Solids. 197. 106068–106068. 10 indexed citations
3.
Zhang, Peijie, Xueyan Chen, Qiongyu Hao, et al.. (2025). Shell-lattice metamaterials with intrinsic contact stabilization for exceptional mechanical performance and nonlinear stability. Journal of the Mechanics and Physics of Solids. 208. 106467–106467.
4.
Hao, Qiongyu, Susanne M. Henning, Clara E. Magyar, et al.. (2024). Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice. Biomolecules. 14(1). 105–105. 6 indexed citations
6.
Hao, Qiongyu, Yanyuan Wu, Jaydutt V. Vadgama, & Piwen Wang. (2022). Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies. Biomolecules. 12(9). 1306–1306. 20 indexed citations
7.
Hao, Qiongyu, Yong Wu, Yanyuan Wu, Piwen Wang, & Jaydutt V. Vadgama. (2022). Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. International Journal of Molecular Sciences. 23(3). 1461–1461. 59 indexed citations
8.
Hao, Qiongyu, Zhimin Huang, Qun Li, et al.. (2022). A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer. Advanced Science. 9(6). e2102303–e2102303. 14 indexed citations
9.
Li, Huamei, et al.. (2022). Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Frontiers in Immunology. 13. 891175–891175. 7 indexed citations
10.
Hao, Qiongyu, et al.. (2022). CircRAD54L2 promotes triple-negative breast cancer progression by regulating the miR-888 family/PDK1 axis. Life Sciences. 312. 121128–121128. 9 indexed citations
11.
Deng, Wenhong, Qiongyu Hao, Jaydutt V. Vadgama, & Yong Wu. (2021). Wild-Type TP53 Predicts Poor Prognosis in Patients with Gastric Cancer. PubMed. 5(1). 134–153. 6 indexed citations
12.
Hao, Qiongyu, Clara E. Magyar, Jin Zhong, et al.. (2020). Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor. Scientific Reports. 10(1). 1403–1403. 21 indexed citations
13.
Li, Qun, Qiongyu Hao, Wei Cao, et al.. (2019). PP2Cδ inhibits p300-mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Science Advances. 5(10). eaaw8417–eaaw8417. 15 indexed citations
14.
Cao, Wei, Jieqing Li, Qiongyu Hao, Jaydutt V. Vadgama, & Yong Wu. (2019). AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer. Breast Cancer Research. 21(1). 29–29. 67 indexed citations
15.
Wu, Ke, Xiaoting Yu, Zhimin Huang, et al.. (2018). Targeting of PP2Cδ By a Small Molecule C23 Inhibits High Glucose-Induced Breast Cancer Progression In Vivo. Antioxidants and Redox Signaling. 30(17). 1983–1998. 12 indexed citations
16.
Liu, Kun, et al.. (2018). MicroRNA-19a/b-3p protect the heart from hypertension-induced pathological cardiac hypertrophy through PDE5A. Journal of Hypertension. 36(9). 1847–1857. 28 indexed citations
17.
Xiao, Jun‐Hua, et al.. (2017). Emerging Role of MicroRNAs and Long Noncoding RNAs in Healthy and Diseased Lung. Advances in experimental medicine and biology. 967. 343–359. 7 indexed citations
18.
Han, Fei, Suxia Zhang, Long Zhang, & Qiongyu Hao. (2017). The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma. Pathology - Research and Practice. 213(12). 1519–1522. 25 indexed citations
19.
Hao, Qiongyu, Jianyuan Luo, Jianping Xiong, et al.. (2015). USP4 inhibits p53 and NF-κB through deubiquitinating and stabilizing HDAC2. Oncogene. 35(22). 2902–2912. 67 indexed citations
20.
Hao, Qiongyu, et al.. (2015). Inositol 1,4,5-trisphosphate activates TRPC3 channels to cause extracellular Ca2+ influx in airway smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 309(12). L1455–L1466. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026